Description
A modulator of RORγ and LXR receptors; an inverse agonist of RORγ (IC50 = ~100 nM) and an agonist of LXR; binds to PPARγ (IC50 = 209 nM) but does not activate it; inhibits LPS-induced expression of TREM-1 in RAW 264.7 cells at 10 μM; inhibits LPS-induced expression of the LXR target genes IL-6 and IL-33 and increases expression of ABCG1, FASN, and SCD-1 in RAW 264.7 cells; reduces severity score in a mouse model of collagen-induced arthritis at 20 mg/kg twice per day; reduces blood glucose levels in a glucose tolerance test, serum levels of total cholesterol and LDL, body weight, and fat mass in a mouse model of high-fat diet-induced obesity
Formal name: 2′-methyl-4′-[[4-(4-pyridinylmethyl)-1-piperazinyl]methyl]-α,α-bis(trifluoromethyl)-[1,1′-biphenyl]-4-methanol
Synonyms:
Molecular weight: 523.5
CAS: 1414248-06-8
Purity: ≥98%
Formulation: A crystalline solid